Abivax (ABVX) News Today $81.64 +2.21 (+2.78%) Closing price 04:00 PM EasternExtended Trading$82.85 +1.21 (+1.48%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ABVX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Affinity Asset Advisors LLC Buys New Position in Abivax SA Sponsored ADR $ABVXAugust 28 at 9:09 AM | marketbeat.com2 Logical Mid-Cap Biotech Buyout TargetsAugust 27 at 1:14 PM | seekingalpha.comShort Interest in Abivax SA Sponsored ADR (NASDAQ:ABVX) Grows By 28.7%August 23, 2025 | marketbeat.comAbivax SA Sponsored ADR $ABVX Holdings Raised by Aberdeen Group plcAugust 23, 2025 | marketbeat.comAbivax SA Sponsored ADR (NASDAQ:ABVX) Sees Significant Growth in Short InterestAugust 23, 2025 | americanbankingnews.comAbivax SA Sponsored ADR (NASDAQ:ABVX) Receives Average Recommendation of "Buy" from BrokeragesAugust 18, 2025 | marketbeat.comAbivax SA Sponsored ADR (NASDAQ:ABVX) Given Consensus Rating of "Buy" by AnalystsAugust 17, 2025 | americanbankingnews.comAbivax (ABVX) to Release Earnings on MondayAugust 5, 2025 | marketbeat.comJMP Securities Sticks to Their Buy Rating for Abivax SA Sponsored ADR (ABVX)August 2, 2025 | theglobeandmail.comPiper Sandler Reaffirms Their Buy Rating on Abivax SA Sponsored ADR (ABVX)August 2, 2025 | theglobeandmail.comPiper Sandler Raised the Firm’s PT on ABIVAX Société (ABVX), Kept an Overweight RatingAugust 2, 2025 | msn.comAbivax (NASDAQ:ABVX) Hits New 1-Year High - Should You Buy?August 1, 2025 | marketbeat.comPiper Sandler Raises Price Target for Abivax (ABVX)August 1, 2025 | msn.comThis Stock Is Up by 800% This Year -- but Is It a Buy?July 31, 2025 | msn.comAbivax (NASDAQ:ABVX) Trading 5.2% Higher on Analyst UpgradeJuly 30, 2025 | marketbeat.comPiper Sandler Issues Positive Forecast for Abivax (NASDAQ:ABVX) Stock PriceJuly 30, 2025 | marketbeat.comAbivax price target raised to $112 from $70 at Piper SandlerJuly 30, 2025 | msn.comAbivax (NASDAQ:ABVX) Sees Strong Trading Volume - Here's What HappenedJuly 29, 2025 | marketbeat.comAbivax Announces Closing of $747.5 Million Public OfferingJuly 28, 2025 | globenewswire.comLeerink Partnrs Issues Negative Forecast for Abivax EarningsJuly 26, 2025 | marketbeat.comLifesci Capital Brokers Lift Earnings Estimates for AbivaxJuly 26, 2025 | marketbeat.comAbivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $747.5M (€637.5M)July 25, 2025 | finance.yahoo.comAbivax Announces Full Exercise of Underwriters' Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $747.5M (€637.5M)July 25, 2025 | globenewswire.comAbivax Hits The Stratosphere, Up Nearly 600%, On 'Potentially Disruptive' ResultsJuly 24, 2025 | msn.comAbivax (ABVX) Skyrockets 586% to New High on Promising Drug Trial, Bullish Analyst OutlooksJuly 24, 2025 | msn.comAbivax: Positive Obefazimod Induction Data Leads To Next 44-Week Maintenance Trial CatalystJuly 24, 2025 | seekingalpha.comPiper Sandler Increases Abivax (NASDAQ:ABVX) Price Target to $70.00July 24, 2025 | marketbeat.comAbivax (NASDAQ:ABVX) Price Target Raised to $101.00 at Lifesci CapitalJuly 24, 2025 | marketbeat.comAbivax announces trading resumption of its ordinary shares on Euronext ParisJuly 24, 2025 | globenewswire.comAbivax Announces Pricing of $650M (€554M) Public Offering of American Depositary SharesJuly 24, 2025 | globenewswire.comAbivax (NASDAQ:ABVX) Hits New 52-Week High on Analyst UpgradeJuly 24, 2025 | marketbeat.comAbivax announces temporary trading halt of its ordinary shares on Euronext ParisJuly 24, 2025 | globenewswire.comAbivax Announces Launch of Public OfferingJuly 23, 2025 | globenewswire.comAbivax: Differentiated Phase 3 Data Ignites A Multi-Billion Dollar OpportunityJuly 23, 2025 | seekingalpha.comAbivax (NASDAQ:ABVX) Trading Up 577.5% on Analyst UpgradeJuly 23, 2025 | marketbeat.comAbivax SA Sponsored ADR (NASDAQ:ABVX) Receives Average Recommendation of "Buy" from AnalystsJuly 23, 2025 | marketbeat.comAbivax (NASDAQ:ABVX) Price Target Raised to $101.00July 23, 2025 | marketbeat.comAbivax (NASDAQ:ABVX) Rating Increased to Overweight at Morgan StanleyJuly 23, 2025 | marketbeat.comJMP Securities Boosts Abivax (NASDAQ:ABVX) Price Target to $95.00July 23, 2025 | marketbeat.comAbivax (NASDAQ:ABVX) Shares Gap Up - Should You Buy?July 22, 2025 | marketbeat.comAbivax (NASDAQ:ABVX) Sees Large Volume Increase - Still a Buy?July 21, 2025 | marketbeat.comAbivax: Good Entry Point Ahead Of The Mega Catalyst - Phase 3 Data ReadoutJuly 19, 2025 | seekingalpha.comAbivax (NASDAQ:ABVX) Trading Down 3% - Should You Sell?July 18, 2025 | marketbeat.comAbivax (NASDAQ:ABVX) Shares Gap Up - What's Next?July 16, 2025 | marketbeat.comAbivax (NASDAQ:ABVX) Sees Large Volume Increase - What's Next?July 15, 2025 | marketbeat.comAbivax (NASDAQ:ABVX) Stock Price Up 6.5% - Here's What HappenedJuly 14, 2025 | marketbeat.comAbivax’s Obefazimod: A Promising Contender in Ulcerative Colitis Treatment with Potential Market ImpactJuly 6, 2025 | tipranks.comPositive Outlook for Abivax SA: Anticipated Success of Obefazimod in Ulcerative Colitis TreatmentJuly 4, 2025 | tipranks.comBuy Rating Justified for Abivax SA: Promising Efficacy of Obefazimod in Ulcerative Colitis and Crohn’s DiseaseJune 24, 2025 | tipranks.comAbivax Announces Results of its June 6, 2025 Annual General MeetingJune 11, 2025 | globenewswire.com Get Abivax News Delivered to You Automatically Sign up to receive the latest news and ratings for ABVX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ABVX Media Mentions By Week ABVX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ABVX News Sentiment▼1.391.02▲Average Medical News Sentiment ABVX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ABVX Articles This Week▼72▲ABVX Articles Average Week Get the Latest News and Ratings for ABVX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Abivax and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies TEVA News Today SMMT News Today GMAB News Today VTRS News Today RDY News Today ASND News Today QGEN News Today MRNA News Today BBIO News Today ELAN News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ABVX) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersNVIDIA's Worst Nightmare?$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhat Are Some Strategies to Help Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abivax SA Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Abivax With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access